- Home
- VRDN vs RXO Comparison
VRDN vs RXO Comparison
Compare VRDN & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRDN | RXO |
|---|---|---|
| Founded | 2006 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | 2014 | 2022 |
Fundamental Metrics
Financial Performance| Metric | VRDN | RXO |
|---|---|---|
| Price | $28.67 | $12.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 15 |
| Target Price | ★ $40.92 | $16.31 |
| AVG Volume (30 Days) | 1.0M | ★ 2.7M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.81 |
| EPS | N/A | ★ N/A |
| Revenue | $5,706,000.00 | ★ $5,742,000,000.00 |
| Revenue This Year | $4.67 | $0.78 |
| Revenue Next Year | $331.57 | $6.58 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.20 |
| 52 Week Low | $9.90 | $10.43 |
| 52 Week High | $34.29 | $19.65 |
Technical Indicators
Market Signals| Indicator | VRDN | RXO |
|---|---|---|
| Relative Strength Index (RSI) | 45.38 | 32.81 |
| Support Level | $26.31 | $10.80 |
| Resistance Level | $33.71 | $16.85 |
| Average True Range (ATR) | 1.58 | 0.96 |
| MACD | 0.04 | -0.42 |
| Stochastic Oscillator | 52.01 | 4.59 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.